May 13, 2021 by Chain Drug Review
Georgia Governor Brian Kemp, NACDS president and chief executive officer Steven Anderson, National Association of Chain Drug Stores (NACDS
Leading Headlines, Pharmacy

ATLANTA –The National Association of Chain Drug Stores (NACDS) is applauding the enactment of three pieces of legislation in Georgia (Act 19, Act 240 and Act 292) which greatly increase patient access to the quality healthcare services provided by pharmacies and pharmacy teams. The measures were signed into law by Georgia Governor Brian Kemp (R). The first measure
December 10, 2020 by Chain Drug Review
Centers for Medicare & Medicaid Services’ (CMS), NACDS president and chief executive officer Steven Anderson, National Association of Chain Drug Stores (NACDS
Leading Headlines, Pharmacy

ARLINGTON, Va.– The National Association of Chain Drug Stores (NACDS) is among the 13 health care entities urging Congress to ensure that the Centers for Medicare & Medicaid Services (CMS) adheres to the January 1, 2022 deadline for compliance with the electronic prescribing of controlled substances (EPCS) requirement. In a letter, NACDS and allied organizations urge
December 4, 2020 by Chain Drug Review
NACDS president and chief executive officer Steven Anderson, National Association of Chain Drug Stores (NACDS
Leading Headlines, Pharmacy

ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) President and CEO Steven Anderson issued a statement today upon the U.S. Department of Health and Human Services’ (HHS) issuance of an amendment to a prior Public Readiness and Emergency Preparedness Act (PREP Act) Declaration: “NACDS had urged HHS to resolve inconsistencies between federal and state
January 30, 2020 by Chain Drug Review
Centers for Disease Control and Prevention (CDC), National Association of Chain Drug Stores (NACDS
Leading Headlines, Pharmacy

ARLINGTON, Va. — Preventive care as a public health strategy can benefit even more from the “clinical expertise and sweeping reach of community pharmacies,” the National Association of Chain Drug Stores (NACDS) advised the Centers for Disease Control and Prevention (CDC) in official comments. NACDS responded to CDC’s request-for-information on priority topics over the next five years
September 23, 2019 by Chain Drug Review
American Public Health Association (APHA), APHA Annual Meeting and Expo, at the Pennsylvania Convention Center in Philadelphia, CDC Foundation, Demonstrating Our Collective Impact: Pharmacy and Public Health Collaborations to Create the Healthiest Nation, National Association of Chain Drug Stores (NACDS, Steven Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS), the American Public Health Association (APHA) and the CDC Foundation will co-host a pre-conference workshop that brings together public health, pharmacy and health care stakeholders to assess gaps in patient care access, leverage partnerships, and analyze practices for improved population health outcomes. The forum—in
September 17, 2019 by Chain Drug Review
Medicaid, National Association of Chain Drug Stores (NACDS, Steven Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va.— Rolling back assurances that Medicaid patients have appropriate health care access in each state would jeopardize health and increase costs, the National Association of Chain Drug Stores (NACDS) told the Centers for Medicare & Medicaid Services (CMS) in official comments. NACDS’ comments take issue with a proposed rule that would repeal the approach
July 17, 2019 by Chain Drug Review
Drug Enforcement Administration’s Automated Reports and Consolidated Ordering System (ARCOS) data, National Association of Chain Drug Stores (NACDS
Leading Headlines, Pharmacy

ARLINGTON, Va. – Following the release of the Drug Enforcement Administration’s Automated Reports and Consolidated Ordering System (ARCOS) data, National Association of Chain Drug Stores (NACDS) president and chief executive officer Steven Anderson issued the following statement regarding pharmacy’s commitment to serving as part of the solution to opioid abuse: “Every day, pharmacists face a
May 30, 2019 by Chain Drug Review
John S. McCain Opioid Addiction Prevention Act (S. 724/H.R. 614), National Association of Chain Drug Stores (NACDS, opioid-abuse prevention, Steven Anderson
Leading Headlines, Pharmacy

ALEXANDRIA, Va. – The National Association of Chain Drug Stores (NACDS) has announced four more policy recommendations for opioid abuse prevention. The new proposals build on current policies backed by NACDS, which are achieving results at the federal and state levels. The new recommendations include: • Prescription drug monitoring program (PDMP) improvements; • Reforms in
May 28, 2019 by Chain Drug Review
NACDS RxIMPACT, National Association of Chain Drug Stores (NACDS, Phair Pricing Act (H.R. 1034/S. 640)
Leading Headlines, Pharmacy

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) RxIMPACT program has launched an Action Alert, urging Congress to provide “DIR fee” relief in time to save pharmacies and to reduce seniors’ out-of-pocket drug costs. Through NACDS RxIMPACT, pharmacy advocates are contacting U.S. Senators and members of the U.S. House of Representatives to
February 12, 2019 by Chain Drug Review
National Association of Chain Drug Stores (NACDS, U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”
Featured Articles, Leading Headlines, Pharmacy

ARLINGTON, Va.—The National Association of Chain Drug Stores (NACDS) Tuesday submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.” NACDS described the importance of direct and indirect remuneration (DIR) fee reform for reducing patients’ out-of-pocket prescription drug costs, and
February 12, 2019 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma, Health and Human Services Secretary Alex Azar, National Association of Chain Drug Stores (NACDS, National Community Pharmacists Association (NCPA), Steven Anderson
Leading Headlines, Pharmacy

ARLINGTON, Va.— The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) Tuesday lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform. In a letter to Health and Human Services Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator
February 5, 2019 by Chain Drug Review
Alex Azar, B. Douglas Hoey, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, National Association of Chain Drug Stores (NACDS, National Community Pharmacists Association (NCPA), Steven Anderson
Leading Headlines, Pharmacy

WASHINGTON — The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) Tuesday praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the Secretary for concepts in the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Modernizing Part D and Medicare Advantage
January 25, 2019 by Chain Drug Review
Centers for Medicare & Medicaid Services, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, National Association of Chain Drug Stores (NACDS, proposal to reform direct and indirect remuneration (DIR) fees
Leading Headlines, Pharmacy

ARLINGTON, Va.—Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees – reform
January 21, 2019 by Chain Drug Review
American Pharmacists Association (APhA), National Association of Chain Drug Stores (NACDS, Steven Anderson, Thomas Menighan, U.S. Food and Drug Administration
Leading Headlines, Pharmacy

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA)